A comparison of the irritant and allergenic properties of antiseptics

European Journal of Dermatology

Volumn 24, Issue 1, 2014, Pages 3-9

  Lachapelle, Jean Marie ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Adaptive immunity; Chlorhexidine; Hexamidinediisethionate; Innate immunity; Octenidine; Polyhexanide; Povidone iodine; Quaternary ammonium compounds; Silver dressings; Triclosan

Indexed keywords

2 PHENOXYETHANOL; 2 PROPANOL; ALKYLDIAMINOETHYLGLYCINE; ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; BRIAL; BROMOCHLOROPHEN; CHEMOTECHNIQUE; CHLORHEXIDINE; HEXAMIDINE ISETIONATE; IMMUNOGLOBULIN E; JODOBA; KODAN; LAVASEPT; MERCURY DERIVATIVE; OCTANILIN; OCTENIDINE; OCTENISEPT; POLY (HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; QUATERNARY AMMONIUM DERIVATIVE; SOFTASEPT; SULFADIAZINE SILVER; SUPRASORB; TRICLOSAN; TROLAB; UNCLASSIFIED DRUG; TOPICAL ANTIINFECTIVE AGENT;

ABDOMINAL ABSCESS; ADAPTIVE IMMUNITY; ALLERGENICITY; ALLERGIC URTICARIA; ANGIONEUROTIC EDEMA; ATOPIC DERMATITIS; BLOOD VESSEL INJURY; BURN DRESSING; CELLULITIS; CHRONIC INFLAMMATION; DEBRIDEMENT; DRUG CYTOTOXICITY; ECZEMA; EFFECTOR CELL; EPITHELIZATION; GENOTOXICITY; HAND WASHING; HISTOCOMPATIBILITY; HUMAN; INNATE IMMUNITY; IRRITANT DERMATITIS; LEG ULCER; LEUKOCYTOCLASTIC VASCULITIS; OCCUPATIONAL ECZEMA; REVIEW; SILVER DRESSING; SKIN ALLERGY; SKIN ANAPHYLAXIS; TISSUE NECROSIS; WOUND HEALING; WOUND IRRIGATION; COMPARATIVE STUDY; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS;

ANTI-INFECTIVE AGENTS, LOCAL; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; HUMANS; POVIDONE-IODINE;

EID: 84897539140     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2198     Document Type: Review

References (62)

1. Osterlund A, Kahlmeter G, Haeggeman S, Olsson-Lijequist B. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study. Scand J Infect Dis 2006; 38: 332-4.
2. Upton A, Lang S, Heffeman H, Mupirocin H. Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003; 51: 613-7.
3. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Pathophysiology and immunological diagnosis. Eur J Dermatol 2009; 19: 1-8.
4. Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009; 64: 1699-714.
5. Nosbaum A, Nicolas JF, Lachapelle JM. Pathophysiology of Allergic and Irritant Contact Dermatitis. In: Patch Testing and Prick Testing. A Practical Guide. Lachapelle JM, Maibach HI (eds), 3nd edn. Berlin, Springer, 2009; 3-9.
6. Goossens A: Le test semi-ouvert. Dermatologie Actualité (Bruxelles) 2003; 79: 16-7.
7. Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986; 14: 221-7.
8. Lepoittevin JP. Molecular Aspects in Allergic and Irritant Contact Dermatitis. In: Johansen JD, Frosch PJ, Lepoittevin J-P, eds. Contact Dermatitis, 5thedn, Berlin, Springer, 2011; 91-110.
9. Müller G, Kramer A. Comparative study of in vitro cytotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel®) and selected antiseptics. Dermatology 2006; 212: 91-3.
10. Quatresooz P, Xaufflaire-Uhoda E, Piérard-Franchimont C, Piérard GE. Regional variability in stratum corneum reactivity to antiseptic formulations. Contact Dermatitis 2007; 56: 271-3.
11. Nagasawa M, Hayashi H, Nakayoshi T. In vitro Evaluation of Skin Sensitivity of Povidone-Iodine and Others Antiseptics Using a Three-Dimensional Human Skin Model. Dermatology 2002; 204 (Suppl 1): 109-13.
12. Kempf M, Kimble RM, Cuttle L. Cytotoxicity testing of burn wound dressings, ointments and creams: method using polycarbonate cell culture inserts on a cell culture system. Burns 2011; 37: 994-1000.
13. Fumal I, Braham C, Paquet P, Piérard-Franchimont C, Piérard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatology 2002; 204 (Suppl 1): 70-4.
14. Harding KG, Jones V, Price P. Topical treatment: which dressing to choose. Diabetes Metal Res Rev 2000; 16 (suppl 1): S47-50.
15. Langer S, SedighSalakdeh M, Goertz O, Steinau HU, Steinstrasser L, Homann HH. The impact of topical antiseptics on skin microcirculation. Eur J Med Res 2004; 29: 449-54.
16. Kalteis T, Lüring C, Schaumburger J, Perlick L, Bäthis H, Grifka J. Tissue toxicity of antiseptics. Z Orthop Ihre Grenzgeb 2003; 141: 233-8.
17. Röhner E, Hoff P, Winkler T, von Roth P, Bengt Seeger J, Perka C. Polyhexanide and hydrogen peroxide inhibit proteoglycan synthesis. J Histotechn 2011; 34: 35-9.
18. Li YC, Kuang YH, Lee SS, Huang FM, Chang YC. Cytotoxicity and genotoxicity of chlorhexidine on macrophages in vitro. Environ Toxicol 2012 Apr 4. doi: 10.1002/tox.21771. [Epub ahead of print].
19. Franz T, Vogelin E. Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept®. J Hand Surg Eur 2012; 37: 61-4.
20. Vanscheidt W, Harding K, Téot L, Siebert J. Effectiveness and tissue compatibility of a 12-week treatment of chronic venous ulcers with an octenidine based antiseptic: a randomized double-blind controlled study. Int Wound J 2012; 9: 316-23.
21. Bauer B, Majic M, Rauthe S, Bröcker EB, Kerstan A. Persistent swelling after flushing of an abscess with Octenisept®. Unfallchirurg 2012; 115: 1116-9.
22. Hübner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 2010; 23: 244-58.
23. Burd A, Kwok CH, Hung SC, et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Rep Reg 2007; 15: 94-104.
24. Lachapelle JM. Antiseptics and Disinfectants. In: Kanerva's Occupational Dermatology. 2ndedn. Rustemeyer Th, Elsner P, John SM, Maibach HI eds. Berlin, Springer, 2012; pp 385-95.
25. Lachapelle JM, de Prost Y. Place de la povidone iodée en dermatologie. Editions Ektopic, Paris, 2007.
26. Lachapelle JM. Occupational allergic contact dermatitis to povidone-iodine. Contact Dermatitis 1984; 11: 189-90.
27. Tosti A, Vincenzi C, Bardazzi F, Mariani R. Allergic contact dermatitis due to povidone iodine. Contact Dermatitis 1990; 23: 197-8.
28. Erdmann S, Herti M, Merk HF. Allergic contact dermatitis from povidone-iodine. Contact Dermatitis 1999; 40: 331-2.
29. Pecquet C. Allergy to iodine. Ann Dermatol Venereol 2003; 130: 795-8.
30. Lachapelle JM. Allergic contact dermatitis from povidone-iodine: a reevaluation study. Contact Dermatitis 2005; 52: 9-10.
31. Lachapelle JM. Thésaurismose cutanée par polyvinylpyrrolidone. Dermatologica 1966; 132: 476-89.
32. Calnan CD. Contact Dermatitis from drugs. Proc R Soc Med 1962; 55: 39-42.
33. Liippo J, Kousa P, Lalmmintausta K. The relevance of chlorhexidine contact allergy. Contact Dermatitis 2011; 64: 229-34.
34. Chemotechnique Patch Test Products, 2012.
35. Muston HL, Boss JM, Summerly R. Dermatitis from Ammonyx 1.0, a constituent of Hibiscrub. Contact Dermatitis 1977; 3: 347-8.
36. Rudzki E, Rebandel P, Grzywa Z. Patch tests with occupational contactants in nurses, doctors and dentists. Contact Dermatitis 1989; 20: 247-50.
37. Rietschel RL, Fowler JF Jr. Fisher's Contact Dermatitis 6. BC Decker inc. Hamilton, Ontario, Canada, 2008.
38. Heinemann C, Sinaiko R, Maibach HI. Contact Urticaria and Anaphylaxis to Chlorhexidine. In: Marzulli and Maibach's Dermatoxicology. 7thedn. Zhai H, Wilhelm K-P, Maibach HI eds. CRC Press, Boca Raton FL, 2008; 485-495.
39. Leysen J, Bridts C, Sabato V, Vercauteren M, Ebo D. Anaphylaxis during general anaesthesia: ten-year survey from a Belgian allergy clinic. European Academy of Allergy and Clinical Immunology, 16-20 June 2012, Geneva (poster 291).
40. Krautheim AB, Jermann THH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004; 50: 113-6.
41. Nagendran V, Wickin J, Ekbote A, et al. IgE-mediated chlorhexidine allergy: a new occupational hazard? Occup Med (Lond) 2009; 59: 270-2.
42. Kramer AW, Daeschlein G, Kammerlander G, et al. An assessment of the evidence on antiseptics: a consensus paper on their use in wound care. J Wound Care 2004; 13: 1-7.
43. Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H. Contact dermatitis due to the use of Octenisept in wound care. J Dtsch Dermatol Ges 2009; 7: 759-65.
44. Minnich KE, Stolarick R, Wilkins RG, Chilson G, Pitt SL, Unverdorben M. The effect of wound care solution containing polyhexanide and betaine on bacterial counts: results of an in vitro study. Ostomy Wound Manage 2012; 58: 32-6.
45. Lenselink E, Andriessen A. A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds. J Wound Care 2011; 534: 536-9.
46. Schnuch A, Geier J, Uter W, Basketter DA, Jowsey IR. The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermatitis 2007; 56: 235-9.
47. Olivieri J, Eigenmann PA, Hauser C. Severe anaphylaxis to a new disinfectant: polyhexanide, a chlorhexidine polymer. Schweiz Med Wochensch 1998; 128: 1508-11.
48. Kautz O, Schumann F, Degerbeck L, Venemalm L, Jakob T. Severe anaphylaxis to the antiseptic polyhexanide. Allergy 2010; 65: 1068-70.
49. Kaehn K. Polyhexanide: a safe and highly effective biocide. Skin Pharmacol Physiol 2010; 23 (suppl): 7-16.
50. Lansdow AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2006; 33: 17-34.
51. Leaper DJ. Silver dressings: their role in wound management. Int Wound J 2006; 3: 282-94.
52. Lidén C, Bruze M, Thyssen JP, Menné T. Metals. In: Johansen JD, Frosch PJ, Lepoittevin J-P, eds. Contact Dermatitis, 5thedn, Springer, Berlin, 2011: 643-79.
53. Corazza M, Virgili A. Airborne allergic contact dermatitis from benzalkonium chloride. Contact Dermatitis 1993; 28: 195-6.
54. Stanford D, Georgouras K. Allergic contact dermatitis from benzalkonium chloride in plaster of Paris. Contact Dermatitis 1996; 35: 371-2.
55. Dooms-Goossens A, Van Daele M, Bedert R, Marien K. Hexamidine isethionate: a sensitizer in topical pharmaceutical products and cosmetics. Contact Dermatitis 1989; 21: 270.
56. Le Coz CJ, Scrivener Y, Santinelli F, Heid E. Sensibilisation de contact au cours des ulcères de jambe. Ann Dermatol Venereol 1998; 125: 694-9.
57. Revuz J, Poli F, Wechsler J, Dubertret L. Dermatites de contact à l'hexamidine. Ann Dermatol Venereol 1984; 111: 805-10.
58. Fransway AL. The problem of preservation in the 1990's: 3. Agents with prevention function independent of formaldehyde release. Am J Contact Dermat 1991; 2: 145-8.
59. Lachapelle JM, Tennstedt D. Low allergenicity of triclosan. Predictive testing in guinea pigs and in humans. Dermatologica 1979; 158: 379-83.
60. Magnusson B, Kligman AM. The identification of contact allergens by animal assay. The guinea-pig maximization test. J Invest Dermatol 1969; 52: 268-76.
61. Bertelsen RJ, Longnecker MP, Lovik M, et al. Triclosan exposure and allergic sensitization in Norwegian children. Allergy 2012; 68: 84-91.
62. Özkaya E, Bozkurt PK. An unusual case of triclosan-induced immunological contact urticaria. Contact Dermatitis 2013; 68: 121-3.